United Therapeutics is pioneering a new frontier ... but we have the really established infrastructure with a long history of taking products from discovery through the clinical trial process ...
2d
Zacks.com on MSNArdelyx (ARDX) Earnings Expected to Grow: Should You Buy?The market expects Ardelyx (ARDX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by U ...
Bioink manufacturers play an important role in bioprinting. Explore our list to see which companies are on the market.
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...
Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. Mr. Paolone plays a key role in advising on a range ...
Entero Therapeutics has named Richard Paolone as interim chief executive.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
As of 2:32:28 PM EST. Market Open. SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., February 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results